AI assistant
Sending…
SELLAS Life Sciences Group, Inc. — Director's Dealing 2014
Jan 16, 2014
33651_dirs_2014-01-16_d3f08033-5cb4-4d64-a35f-7760ee9de5e3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2014-01-14
Reporting Person: Hillsberg Sanford (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-01-14 | Common Stock | M | 200000 | $0.85 | Acquired | 334873 | Indirect |
| 2014-01-14 | Common Stock | F | 24426 | $6.96 | Disposed | 310447 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-01-14 | Stock Option | $0.85 | M | 200000 | Disposed | 2021-09-27 | Common Stock (200000) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 17974 | Direct |
More from SELLAS Life Sciences Group, Inc.
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 12
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 20
Major Shareholding Notification
2026
Jan 30
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9